These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16009896)

  • 1. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months.
    Schott JM; Price SL; Frost C; Whitwell JL; Rossor MN; Fox NC
    Neurology; 2005 Jul; 65(1):119-24. PubMed ID: 16009896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus.
    Ezekiel F; Chao L; Kornak J; Du AT; Cardenas V; Truran D; Jagust W; Chui H; Miller B; Yaffe K; Schuff N; Weiner M
    Alzheimer Dis Assoc Disord; 2004; 18(4):196-201. PubMed ID: 15592130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.
    Ridha BH; Anderson VM; Barnes J; Boyes RG; Price SL; Rossor MN; Whitwell JL; Jenkins L; Black RS; Grundman M; Fox NC
    J Neurol; 2008 Apr; 255(4):567-74. PubMed ID: 18274807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI.
    Preboske GM; Gunter JL; Ward CP; Jack CR
    Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease.
    Bradley KM; Bydder GM; Budge MM; Hajnal JV; White SJ; Ripley BD; Smith AD
    Br J Radiol; 2002 Jun; 75(894):506-13. PubMed ID: 12124237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.
    Leung KK; Clarkson MJ; Bartlett JW; Clegg S; Jack CR; Weiner MW; Fox NC; Ourselin S;
    Neuroimage; 2010 Apr; 50(2):516-23. PubMed ID: 20034579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
    Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
    Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
    J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.
    Fox NC; Cousens S; Scahill R; Harvey RJ; Rossor MN
    Arch Neurol; 2000 Mar; 57(3):339-44. PubMed ID: 10714659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid burden is not associated with rates of brain atrophy.
    Josephs KA; Whitwell JL; Ahmed Z; Shiung MM; Weigand SD; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Dickson DW; Jack CR
    Ann Neurol; 2008 Feb; 63(2):204-12. PubMed ID: 17894374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.
    Schott JM; Bartlett JW; Barnes J; Leung KK; Ourselin S; Fox NC;
    Neurobiol Aging; 2010 Aug; 31(8):1452-62, 1462.e1-2. PubMed ID: 20620665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.
    Fox NC; Freeborough PA
    J Magn Reson Imaging; 1997; 7(6):1069-75. PubMed ID: 9400851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent multi-time-point brain atrophy estimation from the boundary shift integral.
    Leung KK; Ridgway GR; Ourselin S; Fox NC;
    Neuroimage; 2012 Feb; 59(4):3995-4005. PubMed ID: 22056457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.
    Schott JM; Frost C; Whitwell JL; Macmanus DG; Boyes RG; Rossor MN; Fox NC
    J Neurol; 2006 Sep; 253(9):1147-53. PubMed ID: 16998650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray matter atrophy rate as a marker of disease progression in AD.
    Anderson VM; Schott JM; Bartlett JW; Leung KK; Miller DH; Fox NC
    Neurobiol Aging; 2012 Jul; 33(7):1194-202. PubMed ID: 21163551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.
    Gordon E; Rohrer JD; Kim LG; Omar R; Rossor MN; Fox NC; Warren JD
    Neurology; 2010 Feb; 74(8):666-73. PubMed ID: 20177120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.
    Camara O; Schnabel JA; Ridgway GR; Crum WR; Douiri A; Scahill RI; Hill DL; Fox NC
    Neuroimage; 2008 Aug; 42(2):696-709. PubMed ID: 18571436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.